Tregs, or regulatory T cells, are specialized immune cells that act as the body’s peacekeepers. By suppressing excessive immune responses, they prevent autoimmune diseases, allergies, and chronic inflammation. Used in cutting-edge therapies, they are crucial for improving organ transplant success and developing targeted cancer treatments. Researchers, immunologists, and pharmaceutical developers benefit most from advancing Treg-based medicine.
Get alerts when this topic surges in newsletters. Free to start.
Sign up freeExplore more trends:Trending Topics ·AI Trends ·Business Trends ·Finance Trends ·Technology Trends